Elanco Animal Health
ELAN
Elanco Animal Health (ELAN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.34
- EPS estimate
- $0.27
- EPS surprise
- +26.30%
- Revenue surprise
- +4.23%
- Revenue
- $1.4B
- Revenue estimate
- $1.3B
- Reported
- Aug 5, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | $0.27 | $0.34 | +26.30% | $1.4B | SEC |
| Q1 2026 | May 6, 2026 | $0.35 | $0.40 | +15.74% | $1.4B | SEC |
| Q4 2025 | Feb 24, 2026 | $0.11 | $0.13 | +14.54% | $1.1B | SEC |
| Q3 2025 | Nov 5, 2025 | $0.13 | $0.19 | +46.15% | $1.1B | SEC |
| Q2 2025 | Aug 7, 2025 | $0.20 | $0.26 | +30.85% | $1.2B | SEC |
| Q1 2025 | May 7, 2025 | $0.31 | $0.37 | +20.80% | $1.2B | SEC |
| Q4 2024 | Feb 25, 2025 | $0.15 | $0.14 | −6.04% | $1.0B | SEC |
| Q3 2024 | Nov 7, 2024 | $0.12 | $0.13 | +6.21% | $1.0B | SEC |
| Q2 2024 | Aug 8, 2024 | $0.24 | $0.30 | +25.16% | $1.2B | SEC |
| Q1 2024 | May 8, 2024 | $0.27 | $0.34 | +24.09% | $1.2B | SEC |
| Q4 2023 | Feb 26, 2024 | $0.10 | $0.08 | −23.44% | $1.0B | SEC |
| Q3 2023 | Nov 7, 2023 | $0.12 | $0.18 | +44.46% | $1.1B | SEC |
| Q2 2023 | Aug 7, 2023 | $0.05 | $0.18 | +282.17% | $1.1B | SEC |
| Q1 2023 | May 9, 2023 | $0.29 | $0.45 | +57.89% | $1.3B | SEC |
| Q4 2022 | Feb 21, 2023 | $0.13 | $0.19 | +49.14% | $988.0M | SEC |
| Q3 2022 | Nov 8, 2022 | $0.16 | $0.20 | +26.10% | $1.0B | — |
| Q2 2022 | Aug 8, 2022 | $0.25 | $0.36 | +42.74% | $1.2B | — |
| Q1 2022 | May 9, 2022 | $0.35 | $0.36 | +1.93% | $1.2B | — |
| Q4 2021 | Feb 24, 2022 | $0.17 | $0.20 | +18.76% | $1.1B | — |
| Q3 2021 | Nov 5, 2021 | $0.17 | $0.19 | +14.94% | $1.1B | — |
Quarterly revenue
Frequently asked questions
When did Elanco Animal Health (ELAN) last report earnings?
Elanco Animal Health last reported on Aug 5, 2026, covering fiscal Q2 2026.
Did ELAN beat earnings estimates?
Yes. Elanco Animal Health reported EPS of $0.34 for Q2 2026 against a $0.27 estimate — a 26.30% beat.
How much revenue did ELAN report last quarter?
Elanco Animal Health reported $1.4B in revenue for Q2 2026, against a consensus estimate of $1.3B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.